We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SLS SELLAS Life Sciences Group Inc

0.05 (4.81%)
Dec 01 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 480,733
Bid Price 1.07
Ask Price 1.09
News -
Day High 1.11


52 Week Range


Day Low 1.04
Company Name Stock Ticker Symbol Market Type
SELLAS Life Sciences Group Inc SLS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.05 4.81% 1.09 19:36:50
Open Price Low Price High Price Close Price Prev Close
1.06 1.04 1.11 1.08 1.04
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,159 480,733 $ 1.07 $ 512,494 - 0.8089 - 4.13
Last Trade Time Type Quantity Stock Price Currency
19:59:53 5 $ 1.0895 USD

SELLAS Life Sciences Group Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
34.31M 32.06M - 1M -41.3M -1.29 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

SELLAS Life Sciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No SLS Message Board. Create One! See More Posts on SLS Message Board See More Message Board Posts

Historical SLS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.001.310.991.04997,6410.099.0%
1 Month0.951.310.80890.9760172859,1780.1414.74%
3 Months1.481.900.80891.11635,683-0.39-26.35%
6 Months1.711.9140.80891.20362,150-0.62-36.26%
1 Year2.424.130.80891.54338,435-1.33-54.96%
3 Years3.8819.380.80899.33741,632-2.79-71.91%
5 Years1.8019.380.112.012,332,129-0.71-39.44%

SELLAS Life Sciences Description

SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |